Annual Shareholders Equity
$544.91 M
+$17.71 M+3.36%
31 December 2023
Summary:
Vanda Pharmaceuticals annual stockholders equity is currently $544.91 million, with the most recent change of +$17.71 million (+3.36%) on 31 December 2023. During the last 3 years, it has risen by +$91.64 million (+20.22%). VNDA annual shareholders equity is now -82.29% below its all-time high of $3.08 billion, reached on 01 December 2003.VNDA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$541.22 M
-$1.29 M-0.24%
30 September 2024
Summary:
Vanda Pharmaceuticals quarterly stockholders equity is currently $541.22 million, with the most recent change of -$1.29 million (-0.24%) on 30 September 2024. Over the past year, it has dropped by -$1.88 million (-0.35%). VNDA quarterly shareholders equity is now -0.68% below its all-time high of $544.91 million, reached on 31 December 2023.VNDA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VNDA Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.4% | -0.3% |
| 3 y3 years | +20.2% | +9.7% |
| 5 y5 years | +97.8% | +35.0% |
VNDA Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +20.2% | -0.7% | +9.7% |
| 5 y | 5 years | at high | +97.8% | -0.7% | +35.0% |
| alltime | all time | -82.3% | +5401.4% | -0.7% | >+9999.0% |
Vanda Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $541.22 M(-0.2%) |
| June 2024 | - | $542.52 M(-0.3%) |
| Mar 2024 | - | $544.00 M(-0.2%) |
| Dec 2023 | $544.91 M(+3.4%) | $544.91 M(+0.3%) |
| Sept 2023 | - | $543.10 M(+0.6%) |
| June 2023 | - | $539.90 M(+0.8%) |
| Mar 2023 | - | $535.74 M(+1.6%) |
| Dec 2022 | $527.20 M(+4.4%) | $527.20 M(+2.2%) |
| Sept 2022 | - | $515.66 M(+1.4%) |
| June 2022 | - | $508.55 M(+1.3%) |
| Mar 2022 | - | $502.12 M(-0.6%) |
| Dec 2021 | $504.93 M(+11.4%) | $504.93 M(+2.4%) |
| Sept 2021 | - | $493.32 M(+2.5%) |
| June 2021 | - | $481.22 M(+2.9%) |
| Mar 2021 | - | $467.63 M(+3.2%) |
| Dec 2020 | $453.27 M(+10.3%) | $453.27 M(+2.9%) |
| Sept 2020 | - | $440.57 M(+2.1%) |
| June 2020 | - | $431.58 M(+3.6%) |
| Mar 2020 | - | $416.39 M(+1.3%) |
| Dec 2019 | $410.94 M(+49.2%) | $410.94 M(+2.5%) |
| Sept 2019 | - | $400.91 M(+35.1%) |
| June 2019 | - | $296.69 M(+6.6%) |
| Mar 2019 | - | $278.40 M(+1.1%) |
| Dec 2018 | $275.42 M(+109.6%) | $275.42 M(+5.4%) |
| Sept 2018 | - | $261.42 M(+4.0%) |
| June 2018 | - | $251.27 M(+4.2%) |
| Mar 2018 | - | $241.14 M(+83.5%) |
| Dec 2017 | $131.39 M(+0.0%) | $131.39 M(+0.7%) |
| Sept 2017 | - | $130.47 M(-0.7%) |
| June 2017 | - | $131.42 M(+2.6%) |
| Mar 2017 | - | $128.14 M(-2.4%) |
| Dec 2016 | $131.33 M(-1.3%) | $131.33 M(+1.7%) |
| Sept 2016 | - | $129.16 M(+6.2%) |
| June 2016 | - | $121.61 M(-1.1%) |
| Mar 2016 | - | $123.01 M(-7.5%) |
| Dec 2015 | $133.03 M(-17.3%) | $133.03 M(-8.8%) |
| Sept 2015 | - | $145.94 M(-2.5%) |
| June 2015 | - | $149.75 M(-1.8%) |
| Mar 2015 | - | $152.47 M(-5.2%) |
| Dec 2014 | $160.82 M(+264.5%) | $160.82 M(>+9900.0%) |
| Sept 2014 | - | $1.06 M(+20.1%) |
| June 2014 | - | $885.00 K(-95.8%) |
| Mar 2014 | - | $20.98 M(-52.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $44.12 M(+345.5%) | $44.12 M(-11.8%) |
| Sept 2013 | - | $50.00 M(+894.9%) |
| June 2013 | - | $5.03 M(-22.5%) |
| Mar 2013 | - | $6.48 M(-34.6%) |
| Dec 2012 | $9.90 M(-70.4%) | $9.90 M(-35.5%) |
| Sept 2012 | - | $15.35 M(-23.6%) |
| June 2012 | - | $20.08 M(-25.4%) |
| Mar 2012 | - | $26.92 M(-19.6%) |
| Dec 2011 | $33.47 M(-11.3%) | $33.47 M(-11.2%) |
| Sept 2011 | - | $37.68 M(-4.7%) |
| June 2011 | - | $39.54 M(-0.1%) |
| Mar 2011 | - | $39.57 M(+4.9%) |
| Dec 2010 | $37.73 M(+63.8%) | $37.73 M(+10.5%) |
| Sept 2010 | - | $34.16 M(+13.7%) |
| June 2010 | - | $30.05 M(+12.8%) |
| Mar 2010 | - | $26.63 M(+15.6%) |
| Dec 2009 | $23.03 M(-50.0%) | $23.03 M(-21.7%) |
| Sept 2009 | - | $29.41 M(-11.7%) |
| June 2009 | - | $33.31 M(-20.4%) |
| Mar 2009 | - | $41.84 M(-9.1%) |
| Dec 2008 | $46.02 M(-45.0%) | $46.02 M(-12.5%) |
| Sept 2008 | - | $52.59 M(-12.5%) |
| June 2008 | - | $60.09 M(-13.7%) |
| Mar 2008 | - | $69.66 M(-16.8%) |
| Dec 2007 | $83.73 M(+212.9%) | $83.73 M(-15.7%) |
| Sept 2007 | - | $99.29 M(-14.4%) |
| June 2007 | - | $116.03 M(-8.5%) |
| Mar 2007 | - | $126.81 M(+373.9%) |
| Dec 2006 | $26.76 M(-12.7%) | $26.76 M(-27.6%) |
| Sept 2006 | - | $36.95 M(-22.3%) |
| June 2006 | - | $47.57 M(+238.3%) |
| Mar 2006 | - | $14.06 M(-54.1%) |
| Dec 2005 | $30.66 M(+92.3%) | $30.66 M |
| Dec 2004 | $15.94 M(-99.5%) | - |
| Dec 2003 | $3.08 B(+17.1%) | - |
| Dec 2002 | $2.63 B(+2.2%) | - |
| Dec 2001 | $2.57 B(+23.7%) | - |
| Dec 2000 | $2.08 B(+1.1%) | - |
| Dec 1999 | $2.06 B(+15.3%) | - |
| Dec 1998 | $1.78 B(+35.7%) | - |
| Dec 1997 | $1.31 B(+375.5%) | - |
| Dec 1996 | $276.30 M(+42.2%) | - |
| Dec 1995 | $194.30 M(+66.5%) | - |
| Dec 1994 | $116.70 M | - |
FAQ
- What is Vanda Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals annual shareholders equity year-on-year change?
- What is Vanda Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Vanda Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of VNDA is $544.91 M
What is the all time high annual shareholders equity for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high annual stockholders equity is $3.08 B
What is Vanda Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, VNDA annual stockholders equity has changed by +$17.71 M (+3.36%)
What is Vanda Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of VNDA is $541.22 M
What is the all time high quarterly shareholders equity for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high quarterly stockholders equity is $544.91 M
What is Vanda Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, VNDA quarterly stockholders equity has changed by -$1.88 M (-0.35%)